The first approved GLP-1 generic weight loss medication (Ranbaxy from Sun Pharma) hit South Africa’s shelves in August.
And with the South African Health Products Regulatory Authority (SAHPRA) considering 13 more applications, will these drugs become affordable for the average patient?
Gugs Mhungu chats to 702 resident GP Dr Fundile Nyati, who notes that the semaglutide-containing medicines first developed to treat Type 2 diabetes, were introduced to the market 20 years ago, which is how long it has taken for the originators’ exclusive…
